Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Colorectal Neoplasms

Free Subscription Articles published in PLoS One Retrieve available abstracts of 216 articles: HTML format

Single Articles

January 2026
1. DANTAS AAG, Oliveira NPD, Martins LFL, de Camargo Cancela M, et al
   Social determinants in the delay of starting colorectal cancer treatment.
   PLoS One. 2026;21:e0338727.
   PubMed     Abstract available
   
   
   
2. SCHOENAKER IJH, van Westreenen HL, Finnema EJ, Schrauwen R, et al
   Diagnostic performance of eNose technology in detecting colorectal cancer recurrence: A prospective evaluation.
   PLoS One. 2026;21:e0340276.
   PubMed     Abstract available
   
   
   
3. MECHLEB K, Hourani N, Fakhry M, Alyamani OA, et al
   Targeting ceramide metabolism to restore hypoxia-induced apoptosis in p53-deficient colon cancer cells.
   PLoS One. 2026;21:e0340295.
   PubMed     Abstract available
   
   
   
4. 
   Editorial Note: The multi-targeted kinase inhibitor sunitinib induces apoptosis in colon cancer cells via PUMA.
   PLoS One. 2026;21:e0339805.
   PubMed    
   
   
   
5. DUAN Z, Li Y, Ren G, Tan M, et al
   Relationships among social support, decision self-efficacy, and decision regret in colorectal chemotherapy cancer patients: A mediating model.
   PLoS One. 2026;21:e0339927.
   PubMed     Abstract available
   
   
   
6. GUO F, Li J, Chen L, Hu J, et al
   Radiomics profiling combined with clinical risk factors for preoperative Lymphatic Metastasis prediction in Colorectal cancer: A multicenter study.
   PLoS One. 2026;21:e0340352.
   PubMed     Abstract available
   
   
   
7. BENNASRALLAH C, Maatouk A, Kacem M, Dhouib W, et al
   Colorectal cancer incidence, survival analysis and predictions (Monastir, Tunisia: 2002-2030).
   PLoS One. 2026;21:e0339603.
   PubMed     Abstract available
   
   
   
8. SCHNEIDER JL, Rivelli JS, Escaron AL, Crocker R, et al
   Impact of COVID-19 on colorectal cancer screening in a federally qualified health center: Provider and staff perspectives.
   PLoS One. 2026;21:e0340184.
   PubMed     Abstract available
   
   
   
9. ZHOU D, Zhou J, Hu B, Yu Y, et al
   Prognostic value of tumor deposits and their different response to neoadjuvant therapy in locally advanced rectal cancer.
   PLoS One. 2026;21:e0340000.
   PubMed     Abstract available
   
   
   
10. JIANG L, Peng Z, Liu R, Chen L, et al
    A study on the effect of CBSM-based psychological intervention on self-management ability and quality of life in colorectal cancer patients from the perspective of benefit finding: A quasi-experimental study.
    PLoS One. 2026;21:e0339472.
    PubMed     Abstract available
    
    
    
11. IBRAHEEM W, Alsheikh F, Alzain AA, Bhongade BA, et al
    Computational repurposing of approved drugs targeting KRAS G12D and EGFR for colorectal cancer therapy.
    PLoS One. 2026;21:e0338123.
    PubMed     Abstract available
    
    
    
12. 
    Retraction: Arctigenin inhibits the progression of colorectal cancer through epithelial-mesenchymal transition via PI3K/Akt/mTOR signaling pathway.
    PLoS One. 2026;21:e0341384.
    PubMed    
    
    
    
13. ZHANG XF, Zhang XL, Xu HW, Lin YH, et al
    ITIH2 in colorectal cancer metastasis: Weighted Gene Co-expression Network Analysis-guided functional validation.
    PLoS One. 2026;21:e0329719.
    PubMed     Abstract available
    
    
    
14. ZUBAIR NF, Mohammed Nawi A, Hassan MR, Daud A, et al
    Multilevel factors influencing colorectal cancer screening adherence: A systematic literature review.
    PLoS One. 2026;21:e0342184.
    PubMed     Abstract available
    
    
    
15. SONG S, Zhang Y, Li L, Zhou K, et al
    Nucleolar protein 6 as a potential oncogenic factor in colorectal cancer.
    PLoS One. 2026;21:e0340047.
    PubMed     Abstract available
    
    
    
16. 
    Correction: Diagnostic performance of eNose technology in detecting colorectal cancer recurrence: A prospective evaluation.
    PLoS One. 2026;21:e0342238.
    PubMed     Abstract available
    
    
    
17. TATSUTA K, Sakata M, Iwaizumi M, Okamoto K, et al
    Clinical impact of hospital distance and center transfers on adherence and outcomes in familial adenomatous polyposis: A multicenter retrospective study in a defined region of Japan.
    PLoS One. 2026;21:e0339401.
    PubMed     Abstract available
    
    
    
18. BUNSUK T, Chantaraamporn J, Mutapat P, Diskul Na Ayudthaya P, et al
    Reducing OGT and O-GlcNAcylation enhance the anticancer effects of oxaliplatin in SW620 metastatic colorectal cancer cells.
    PLoS One. 2026;21:e0341971.
    PubMed     Abstract available
    
    
    
19. KIM HS, Kim J, Lee B, Lee Y, et al
    The role of exosomal miRNA-125b derived from colon cancer-associated fibroblasts in skeletal muscle cachexia.
    PLoS One. 2026;21:e0342052.
    PubMed     Abstract available
    
    
    
20. WANG Z, Ma L, Sun Z, Lv H, et al
    Elucidating key targets and mechanisms of diethyl phthalate-induced colorectal cancer through network toxicology and molecular docking.
    PLoS One. 2026;21:e0343038.
    PubMed     Abstract available
    
    
    January 2025
21. KANG SJ, Park J, Choi GS, Kim JG, et al
    Effects of maximum dose on local control after stereotactic body radiotherapy for oligometastatic tumors of colorectal cancer.
    PLoS One. 2025;20:e0313438.
    PubMed     Abstract available
    
    
    
22. LEE H, Ko DS, Heo HJ, Baek SE, et al
    Uncovering NK cell sabotage in gut diseases via single cell transcriptomics.
    PLoS One. 2025;20:e0315981.
    PubMed     Abstract available
    
    
    
23. DYER CEF, Jin F, Roberts JM, Poynten IM, et al
    Self- versus clinician-collected swabs in anal cancer screening: A clinical trial.
    PLoS One. 2025;20:e0312781.
    PubMed     Abstract available
    
    
    
24. AYERS GD, Cohen AS, Bae SW, Wen X, et al
    Reproducibility and repeatability of 18F-(2S, 4R)-4-fluoroglutamine PET imaging in preclinical oncology models.
    PLoS One. 2025;20:e0313123.
    PubMed     Abstract available
    
    
    
25. DUARTE AX, Silva KA, Ferreira IB, Gontijo CA, et al
    Increased consumption of ultra-processed foods and worse diet quality in colorectal cancer patients after colostomy: A prospective study.
    PLoS One. 2025;20:e0310320.
    PubMed     Abstract available
    
    
    
26. KUMAR V, Golzarri-Arroyo L, Roth S, Imperiale TF, et al
    Effect of the COVID-19 pandemic on colorectal cancer screening in two university-affiliated health care systems.
    PLoS One. 2025;20:e0317057.
    PubMed     Abstract available
    
    
    
27. LI Q, Li Y, Zhou T, Zhang Y, et al
    FBXW7 metabolic reprogramming inhibits the development of colon cancer by down-regulating the activity of arginine/mToR pathways.
    PLoS One. 2025;20:e0317294.
    PubMed     Abstract available
    
    
    
28. ZHENG A, Xu H, Tao Y, Chen B, et al
    Comparative evaluation of TNM staging systems (eighth vs. ninth edition) for the non-surgical treatment of localized and locally advanced anal squamous cell carcinoma: Prognostic significance of T classification and lymph node status.
    PLoS One. 2025;20:e0317598.
    PubMed     Abstract available
    
    
    
29. ANOSOVA O, Head A, Collins B, Alexiou A, et al
    Estimating the burden of underdiagnosis within England: A modelling study of linked primary care data.
    PLoS One. 2025;20:e0313877.
    PubMed     Abstract available
    
    
    
30. HE Y, Liu F, Li Q, Jiang Z, et al
    Identification of cuproptosis and ferroptosis-related subtypes and development of a prognostic signature in colon cancer.
    PLoS One. 2025;20:e0307013.
    PubMed     Abstract available
    
    
    
31. MULENGA M, Rajamanikam A, Kumar S, Muhammad SB, et al
    Revolutionizing colorectal cancer detection: A breakthrough in microbiome data analysis.
    PLoS One. 2025;20:e0316493.
    PubMed     Abstract available
    
    
    
32. GUO R, Wei W
    Association between lipid accumulation product and the risk of colon cancer in adults: A population-based study.
    PLoS One. 2025;20:e0317462.
    PubMed     Abstract available
    
    
    
33. SUN Y, Zhou T, Ye S, Lau EYT, et al
    Exploration of different quantitative polymerase chain reaction-based genotyping methods to distinguish Apcmin/+ mice from wildtype mice.
    PLoS One. 2025;20:e0317038.
    PubMed     Abstract available
    
    
    
34. JIRAMITMONGKON K, Rotkrua P, Khanchaitit P, Arunpanichlert J, et al
    Multifunctional molecular hybrid for targeted colorectal cancer cells: Integrating doxorubicin, AS1411 aptamer, and T9/U4 ASO.
    PLoS One. 2025;20:e0317559.
    PubMed     Abstract available
    
    
    
35. CAZORLA G, Redmond NM, Lamouroux A, Boirot A, et al
    Acceptability and implementation potential of colorectal cancer screening and health literacy training: A qualitative study among general practitioners in deprived areas.
    PLoS One. 2025;20:e0317910.
    PubMed     Abstract available
    
    
    
36. HUANG M, Li J, Huang W, Zhou Y, et al
    The effectiveness of Evodia rutaecarpa hot compress on the recovery of gastrointestinal function after laparoscopic surgery for colorectal cancer: A propensity score-matched retrospective cohort study.
    PLoS One. 2025;20:e0303951.
    PubMed     Abstract available
    
    
    
37. KOUDAHL CONRAD JB, Vesterman Henriksen T, Berg Nors J, Heilskov Rasmussen M, et al
    The role of renal and liver function in clinical ctDNA testing.
    PLoS One. 2025;20:e0319194.
    PubMed     Abstract available
    
    
    
38. LI L, Ji Z, Li G, Gu H, et al
    FAM50A as a novel prognostic marker modulates the proliferation of colorectal cancer cells via CylinA2/CDK2 pathway.
    PLoS One. 2025;20:e0318776.
    PubMed     Abstract available
    
    
    
39. TOMIMATSU H, Fujimoto K, Suto T, Matsuo M, et al
    Prognosis of extracolonic findings on clinical computed tomographic colonography: A single-center experience.
    PLoS One. 2025;20:e0315601.
    PubMed     Abstract available
    
    
    
40. MALLARI MA, Singh A, Shubella J, Khaliq W, et al
    Cancer screening prevalence and preference among hospitalized women with and without diabetes mellitus.
    PLoS One. 2025;20:e0319681.
    PubMed     Abstract available
    
    
    
41. BOVINDER YLITALO E, Vidman L, Harlid S, Van Guelpen B, et al
    mRNA extracted from frozen buffy coat samples stored long term in tubes with no RNA preservative shows promise for downstream sequencing analyses.
    PLoS One. 2025;20:e0318834.
    PubMed     Abstract available
    
    
    
42. LANGIU M, Crescence L, Mege D, Dubois C, et al
    Consequences of platelet-educated cancer cells on the expression of inflammatory and metastatic glycoproteins.
    PLoS One. 2025;20:e0317096.
    PubMed     Abstract available
    
    
    
43. MIGNOZZI S, De Pinto G, Guglielmetti S, Riso P, et al
    Role of aspirin on colorectal cancer risk and bacterial translocation to bloodstream.
    PLoS One. 2025;20:e0319750.
    PubMed     Abstract available
    
    
    
44. WANG Y, Chen B, Yu J
    A machine learning-based model for predicting survival in patients with Rectosigmoid Cancer.
    PLoS One. 2025;20:e0319248.
    PubMed     Abstract available
    
    
    
45. OHASHI Y, Miyo M, Okuya K, Akizuki E, et al
    Impact of double-bolus tracking to individualize scan timing of the portal venous phase in preoperative computed tomography colonography angiography for right-sided colon cancer.
    PLoS One. 2025;20:e0320630.
    PubMed     Abstract available
    
    
    
46. MOTOSUGI S, Takahashi N, Mineo S, Sato K, et al
    Enrichment of Porphyromonas gingivalis in colonic mucosa-associated microbiota and its enhanced adhesion to epithelium in colorectal carcinogenesis: Insights from in vivo and clinical studies.
    PLoS One. 2025;20:e0320383.
    PubMed     Abstract available
    
    
    
47. WANG Y, Feng S, Chen J, Li Y, et al
    Association between serum 25-hydroxyvitamin D concentration and the risk of colorectal cancer: A cross-sectional study.
    PLoS One. 2025;20:e0320335.
    PubMed     Abstract available
    
    
    
48. MAHMUD S, Ajadee A, Sarker A, Ahmmed R, et al
    Exploring common genomic biomarkers to disclose common drugs for the treatment of colorectal cancer and hepatocellular carcinoma with type-2 diabetes through transcriptomics analysis.
    PLoS One. 2025;20:e0319028.
    PubMed     Abstract available
    
    
    
49. CHERAGHI-SHAVI T, Jalal R, Minuchehr Z, Mahjoubi F, et al
    Correction: TGM2, HMGA2, FXYD3, and LGALS4 genes as biomarkers in acquired oxaliplatin resistance of human colorectal cancer: A systems biology approach.
    PLoS One. 2025;20:e0322319.
    PubMed     Abstract available
    
    
    
50. ALSADHAN N, Brennan C, Alhurishi SA, Shuweihdi F, et al
    Factors influencing colorectal cancer screening decisions among Saudi women: A qualitative study.
    PLoS One. 2025;20:e0321086.
    PubMed     Abstract available
    
    
    
51. JIANG L, Liu R, Wang F, Tan X, et al
    Development of a psychological management intervention protocol for colorectal cancer patients: a Delphi study on benefit finding.
    PLoS One. 2025;20:e0321396.
    PubMed     Abstract available
    
    
    
52. WANG Q, Zeng L, Gao L, Xu H, et al
    The longitudinal relationship between depression and anxiety in colorectal cancer patients undergoing chemotherapy and family caregivers: A cross lagged panel model.
    PLoS One. 2025;20:e0319622.
    PubMed     Abstract available
    
    
    
53. WU J, Dong Y, Zhu W, Meng J, et al
    Capecitabine metronomic chemotherapy for metastatic colorectal cancer patients reaching NED: A protocol for a prospective, randomized, controlled trial.
    PLoS One. 2025;20:e0320591.
    PubMed     Abstract available
    
    
    
54. MARTINEZ-RIOS J, Lopez-Pacheco CP, Garcia-Zepeda EA, Soldevila G, et al
    CCR9 shapes the immune microenvironment of colorectal cancer modulating the balance between intratumoral CD8+ T cell and FoxP3+ Helios+ Treg subpopulations.
    PLoS One. 2025;20:e0321930.
    PubMed     Abstract available
    
    
    
55. HAI MINH N, Quy TQ, Tam ND, Tuan TM, et al
    A practical approach for colorectal cancer diagnosis based on machine learning.
    PLoS One. 2025;20:e0321009.
    PubMed     Abstract available
    
    
    
56. MCCREADY TM, Cohen EM, Laynor G, Chebli P, et al
    Addressing the immigrant screening gap: A protocol for a systematic review on interventions to enhance colorectal cancer screening among immigrants in the United States.
    PLoS One. 2025;20:e0322038.
    PubMed     Abstract available
    
    
    
57. SANCHEZ-SANTIESTEBAN D, Patino-Benavidez AF, Buitrago G
    Socioeconomic inequalities of 3-year survival in formal employees with colorectal cancer between 2012 and 2019 in Colombia.
    PLoS One. 2025;20:e0316061.
    PubMed     Abstract available
    
    
    
58. KANG D, Li J, Li Y, Xu J, et al
    Prognostic significance of KRAS, NRAS, BRAF, and PIK3CA mutations in stage II/III colorectal cancer: A retrospective study and meta-analysis.
    PLoS One. 2025;20:e0320783.
    PubMed     Abstract available
    
    
    
59. SONDEJ D, Pigon-Zajac D, Jaszek M, Stefaniuk D, et al
    Is laccase from medicinal mushroom Cerrena unicolor cytotoxic to colon cancer cell line CT-26?
    PLoS One. 2025;20:e0322211.
    PubMed     Abstract available
    
    
    
60. WANG J, Li J, Huo J, Zhao Y, et al
    Fibrinogen and colorectal cancer: A study of the Chinese population.
    PLoS One. 2025;20:e0322789.
    PubMed     Abstract available
    
    
    
61. DITE GS, Wong CK, Gafni A, Spaeth E, et al
    Colorectal cancer risk prediction using a simple multivariable model.
    PLoS One. 2025;20:e0321641.
    PubMed     Abstract available
    
    
    
62. PHILIBERT R, Beach SRH, Mills JA, Dawes K, et al
    Epigenetic assessments of alcohol consumption predict mortality in smokers at risk for lung cancer in the prostate, lung, colorectal and ovarian cancer screening trial.
    PLoS One. 2025;20:e0322783.
    PubMed     Abstract available
    
    
    
63. YANG L, Chen X, Zhong M, Pan Z, et al
    Multivariable prediction of early malignancy detection among first-degree relatives of patients with hereditary colorectal cancer based on the health belief model: A cross-sectional study from the largest hereditary colorectal cancer cohort in China.
    PLoS One. 2025;20:e0323369.
    PubMed     Abstract available
    
    
    
64. STRUSKI L, Urbanczyk T, Bucki K, Cupial B, et al
    MeVGAN: GAN-based plugin model for video generation with applications in colonoscopy.
    PLoS One. 2025;20:e0312038.
    PubMed     Abstract available
    
    
    
65. GROSSMANNOVA K, Belvoncikova P, Puzderova B, Simko V, et al
    Carbonic anhydrase IX downregulation linked to disruption of HIF-1, NFkappaB and STAT3 pathways as a new mechanism of ibuprofen anti-cancer effect.
    PLoS One. 2025;20:e0323635.
    PubMed     Abstract available
    
    
    
66. JIN'O Y, Ushikai M, Komaki Y, Masuda K, et al
    Involvement of community pharmacy pharmacists in fecal immunochemical test screening without government support in Japan.
    PLoS One. 2025;20:e0322879.
    PubMed     Abstract available
    
    
    
67. JEON H, Lee JL, Shim H, Joe S, et al
    Genetic variations and recurrence in stage III Korean colorectal cancer: Insights from tumor-only mutation analysis.
    PLoS One. 2025;20:e0323302.
    PubMed     Abstract available
    
    
    
68. RAHIMI F, Rezayatmand R, Dalvand Z, Ravankhah Z, et al
    Factors influencing participation in colorectal cancer screening among average-risk populations: A descriptive-analytical study in a developing country.
    PLoS One. 2025;20:e0323291.
    PubMed     Abstract available
    
    
    
69. SAITO H, Murakami M, Ozaki A, Nishikawa Y, et al
    Estimating the impact of missed colorectal cancer diagnoses on life expectancy in Minamisoma City following the 2011 triple disaster.
    PLoS One. 2025;20:e0324822.
    PubMed     Abstract available
    
    
    
70. ZHOU Q, Qian L, Shen C, Bei X, et al
    Automated VMAT planning for short-course radiotherapy in locally advanced rectal cancer.
    PLoS One. 2025;20:e0325567.
    PubMed     Abstract available
    
    
    
71. CURTIS AA, Yu Y, Carey M, Yilmaz YE, et al
    A genome-wide SNP-SNP interaction analysis exploring novel interacting loci associated with the risk of recurrence in colorectal cancer.
    PLoS One. 2025;20:e0321967.
    PubMed     Abstract available
    
    
    
72. SHAYKEVICH A, Chae D, Silverman I, Goel S, et al
    Modulating autophagy in KRAS mutant colorectal cancer using combination of oncolytic reovirus and carbamazepine.
    PLoS One. 2025;20:e0326029.
    PubMed     Abstract available
    
    
    
73. WU W, Li A, Singh V, Salner A, et al
    Pain, fatigue, and associated gene expressions over chemotherapy in patients with colorectal cancer.
    PLoS One. 2025;20:e0325849.
    PubMed     Abstract available
    
    
    
74. CHO NY, Kim S, Hadaya J, Chervu N, et al
    Association of center-level operative volume and acute outcomes following robotic-assisted colectomy for colorectal cancer.
    PLoS One. 2025;20:e0299174.
    PubMed     Abstract available
    
    
    
75. ABDELMAKSOUD-DAMMAK R, Ammous-Boukhris N, Saadallah-Kallel A, Ayed-Guerfali DB, et al
    Genetic profiling of inherited colorectal cancer syndromes in Tunisian patients.
    PLoS One. 2025;20:e0326343.
    PubMed     Abstract available
    
    
    
76. AOKI Y, Miki A, Sakuma Y, Watanabe J, et al
    Clinical impact of low bone mineral density in patients with colorectal cancer liver metastasis undergoing hepatectomy.
    PLoS One. 2025;20:e0324719.
    PubMed     Abstract available
    
    
    
77. GEBREAL A, Abdeltawab K, Hesham O, Kolkas S, et al
    Mapping the colorectal cancer patient journey in Egypt: A qualitative study of diagnosis, treatment, and lifestyle perspectives.
    PLoS One. 2025;20:e0326144.
    PubMed     Abstract available
    
    
    
78. ZHANG H, Wang D, Tong Z, Xiang T, et al
    Biweekly CAPOX versus triweekly CAPOX in the adjuvant therapy of post-surgery CRC: A randomized controlled trial.
    PLoS One. 2025;20:e0313472.
    PubMed     Abstract available
    
    
    
79. 
    Retraction: Role of metformin in suppressing 1,2-dimethylhydrazine-induced colon cancer in diabetic and non-diabetic mice: Effect on tumor angiogenesis and cell proliferation.
    PLoS One. 2025;20:e0328096.
    PubMed    
    
    
    
80. FAZAL M, Kanwal S, Raza MT, Razzaque A, et al
    Exploring entropy measures with topological indices on colorectal cancer drugs using curvilinear regression analysis and machine learning approaches.
    PLoS One. 2025;20:e0327369.
    PubMed     Abstract available
    
    
    
81. KLDIASHVILI E, Abiatari I, Kekelia E, Iordanishvili S, et al
    SOX2, PIWI proteins, and MALAT1 - plasma-based emerging biomarkers for cancer detection and monitoring.
    PLoS One. 2025;20:e0328557.
    PubMed     Abstract available
    
    
    
82. WANG YW, Huang ZY, Jin CX, Shen XH, et al
    Unveiling the link: Evaluating MTHFR gene polymorphisms and colorectal cancer risk through meta-analysis.
    PLoS One. 2025;20:e0305517.
    PubMed     Abstract available
    
    
    
83. LI D, Cai Q, Xu F, Lin L, et al
    Unraveling SREBF1's role in elevating colorectal cancer prognosis through proliferation and migration inhibition.
    PLoS One. 2025;20:e0327503.
    PubMed     Abstract available
    
    
    
84. 
    Retraction: Resveratrol inhibits invasion and metastasis of colorectal cancer cells via MALAT1 mediated Wnt/beta-catenin signal pathway.
    PLoS One. 2025;20:e0328012.
    PubMed    
    
    
    
85. QIU X, Li R, Xie G, Ning N, et al
    In vitro 3D drug sensitivity testing for patient-derived tumor-like cell clusters and whole-exome sequencing to personalize postoperative treatment: A study protocol for a multicenter randomized controlled trial.
    PLoS One. 2025;20:e0326760.
    PubMed     Abstract available
    
    
    
86. 
    Retraction: Berberine inhibits invasion and metastasis of colorectal cancer cells via COX-2/PGE2 mediated JAK2/STAT3 signaling pathway.
    PLoS One. 2025;20:e0328009.
    PubMed    
    
    
    
87. YANG M, Narasimhan VM, Zhan FB
    Spatial insights into colorectal cancer risk factors and priority areas for screening in the United Kingdom based on data from the UK Biobank.
    PLoS One. 2025;20:e0328778.
    PubMed     Abstract available
    
    
    
88. YAO C, Hu M, Zhou L, Chen H, et al
    Establishment of two pathomic-based machine learning models to predict CLCA1 expression in colon adenocarcinoma.
    PLoS One. 2025;20:e0328220.
    PubMed     Abstract available
    
    
    
89. WANG Y, Yuan Z, Lao Y, He J, et al
    Mechanistic investigation of glycolysis and pyroptosis in colon adenocarcinoma tissues, and prognostic analysis of patient clinical outcomes.
    PLoS One. 2025;20:e0328560.
    PubMed     Abstract available
    
    
    
90. WANG ZY, Shi GX, Wang Y, Pei W, et al
    Electroacupuncture versus sham electroacupuncture in treating low anterior resection syndrome after rectal cancer surgery: Study protocol for a randomized controlled trial.
    PLoS One. 2025;20:e0329035.
    PubMed     Abstract available
    
    
    
91. 
    Retraction: Chemopreventive Evaluation of a Schiff Base Derived Copper (II) Complex against Azoxymethane-Induced Colorectal Cancer in Rats.
    PLoS One. 2025;20:e0328986.
    PubMed    
    
    
    
92. BAI F, Yin H, Zhang S, Wei D, et al
    Effect of individualized PEEP on lung ultrasound score and optic nerve sheath diameter in elderly patients undergoing laparoscopic rectal cancer surgery: A randomized controlled trial.
    PLoS One. 2025;20:e0328067.
    PubMed     Abstract available
    
    
    
93. TSAI MH, Vo JB, Moore JX, Ramin C, et al
    Mediating effects of mental and physical health on the association between chronic disease conditions and colorectal cancer screening utilization among breast cancer survivors.
    PLoS One. 2025;20:e0328353.
    PubMed     Abstract available
    
    
    
94. BOIROT A, Addamiano MC, Casanova C, Redmond NM, et al
    Acceptability and implementation potential of a health literacy intervention to increase colorectal cancer screening in deprived areas: A qualitative study of patients and general practitioners participating in a cluster randomized controlled trial.
    PLoS One. 2025;20:e0329639.
    PubMed     Abstract available
    
    
    
95. KHATRI RB, Endalamaw A, Darssan D, Assefa Y, et al
    A scoping review of the levels, implementation strategies, enablers, and barriers to cervical, breast, and colorectal cancer screening among migrant populations in selected English-speaking high-income countries.
    PLoS One. 2025;20:e0329854.
    PubMed     Abstract available
    
    
    
96. LEE Y, Silva SG, Gonzalez-Guarda RM
    Social determinants of health, health behaviors, and general health among colorectal cancer survivors: A cross-sectional study.
    PLoS One. 2025;20:e0329752.
    PubMed     Abstract available
    
    
    
97. CHEN N, Zang B, Chen Y
    Predicting one-year post-surgical recurrence in colorectal liver metastasis using CT radiomics and machine learning.
    PLoS One. 2025;20:e0330828.
    PubMed     Abstract available
    
    
    
98. TAKAMI T, Itatani Y, Yoshida Y, Hoshino N, et al
    Protocol for a study to evaluate the safety and efficacy of prophylactic negative pressure wound therapy after abdominal perineal resection (VACPAC study).
    PLoS One. 2025;20:e0331361.
    PubMed     Abstract available
    
    
    
99. TABASSUM N, Hossan ME, Islam MM, Hasan M, et al
    Cheminformatics-based screening and evaluation of phytochemicals as CDK2 inhibitors in colorectal cancer therapy.
    PLoS One. 2025;20:e0331438.
    PubMed     Abstract available
    
    
    
100. WANG J, Li J, Huo J, Zhao Y, et al
     Correction: Fibrinogen and colorectal cancer: A study of the Chinese population.
     PLoS One. 2025;20:e0332402.
     PubMed     Abstract available
     
     
     
101. BIE AKL, Handberg Juul Martiny F, Jauernik CP, Rahbek OJ, et al
     Physical harms in colorectal cancer screening: An overview of the reporting in systematic reviews and randomised controlled trials.
     PLoS One. 2025;20:e0331104.
     PubMed     Abstract available
     
     
     
102. ZHU M, Wang X, Zhang D, Chen A, et al
     Global, regional, and national burdens of five main digestive system cancers in adolescents and young adults from 1990 to 2021 based on the Global Burden of Disease Study 2021: A cross-sectional study.
     PLoS One. 2025;20:e0329377.
     PubMed     Abstract available
     
     
     
103. ROUHOLLAHI MR, Aghili M, Nemati S, Mohagheghi MA, et al
     "Colorectal Cancer Care Quality in a Developing Country: Insights from a Comparison of Teaching and Non-teaching Hospitals in Iran".
     PLoS One. 2025;20:e0326796.
     PubMed     Abstract available
     
     
     
104. READ OJ, Bre J, Zhang Y, Mullen P, et al
     A phosphoramidate modification of FUDR, NUC-3373, causes DNA damage and DAMPs release from colorectal cancer cells, potentiating lymphocyte-induced cell death.
     PLoS One. 2025;20:e0331567.
     PubMed     Abstract available
     
     
     
105. BIE Y, Bie M, Liu W, Tao S, et al
     ZBTB7A regulates CD95-mediated cell growth in colorectal cancer cell lines.
     PLoS One. 2025;20:e0329958.
     PubMed     Abstract available
     
     
     
106. LEE JO, Kim CY, Lee S, Chung JH, et al
     Multi-cancer analysis of histopathologic MSI screening based on digital histology image.
     PLoS One. 2025;20:e0332034.
     PubMed     Abstract available
     
     
     
107. NAES SM, Ab-Rahim S, Mazlan M, Syafruddin SE, et al
     CRISPR/Cas9 mediated ENT2 gene knockout altered purine catabolic pathway and induced apoptosis in colorectal cell lines.
     PLoS One. 2025;20:e0329501.
     PubMed     Abstract available
     
     
     
108. ALSHAHRANI MM
     Structural stability-guided scaffold hopping and computational modeling of tankyrase inhibitors targeting colorectal cancer.
     PLoS One. 2025;20:e0332798.
     PubMed     Abstract available
     
     
     
109. KWAO-ZIGAH G, Bediako-Bowan A, Atampugbire GA, Kwayisi-Darkwah CK, et al
     Association of serum intestinal fatty-acid binding protein, inflammatory and oxidative stress markers with colorectal cancer among Ghanaian patients.
     PLoS One. 2025;20:e0333799.
     PubMed     Abstract available
     
     
     
110. WU W, Mols F, Bonhof CS, Maas L, et al
     Association of ageing-related biomarkers with peripheral neuropathy in colorectal cancer patients up to 2 years after diagnosis.
     PLoS One. 2025;20:e0332579.
     PubMed     Abstract available
     
     
     
111. YUAN W, Liu L
     Immune subtyping of lymph node metastasis-negative colorectal cancer reveals biomarkers for prognosis and immunotherapy response.
     PLoS One. 2025;20:e0332915.
     PubMed     Abstract available
     
     
     
112. BARDAWEEL SK, Abu Sneineh B, Hajjo R, Abu Khalaf R, et al
     DPP4 inhibitors as a novel therapeutic strategy in colorectal cancer: Integrating network biology and experimental insights.
     PLoS One. 2025;20:e0334223.
     PubMed     Abstract available
     
     
     
113. ABU ALSAMEN DR, Zakaraya ZZ, Abed A, Alsa'd AA, et al
     Synergistic anticancer effects of ABT-199 and Vorinostat encapsulated in PLGA nanoparticles: Formulation, characterization, and antiproliferative effects against colorectal cancer cells.
     PLoS One. 2025;20:e0334427.
     PubMed     Abstract available
     
     
     
114. MALAGON M, Ramio-Pujol S, Serrano M, Amoedo J, et al
     Correction: New fecal bacterial signature for colorectal cancer screening reduces the fecal immunochemical test false-positive rate in a screening population.
     PLoS One. 2025;20:e0334314.
     PubMed     Abstract available
     
     
     
115. CAO Y, Yang L, Fan L, Liu X, et al
     Trends in incidence, mortality and disability-adjusted life years of colorectal cancer in East Asia (1990-2021): An analysis of the Global Burden of Disease study 2021.
     PLoS One. 2025;20:e0334229.
     PubMed     Abstract available
     
     
     
116. MORSHNEVA A, Gnedina O, Igotti M
     An in vitro tumor recurrence model based on platinum-resistant colon cancer cells as a research tool for studying cancer cell dormancy.
     PLoS One. 2025;20:e0333671.
     PubMed     Abstract available
     
     
     
117. VAHED IE, Esmaili Z, Mamaghani MP, Farshid S, et al
     The association between serum lipid levels and colorectal cancer risk: A dose-response meta-analysis of 23 studies.
     PLoS One. 2025;20:e0333907.
     PubMed     Abstract available
     
     
     
118. YEW WN, Dean CJ, Chan DKH
     STAG2 mutations in the normal colon induce upregulation of oncogenic pathways in neighbouring wildtype cells.
     PLoS One. 2025;20:pone.
     PubMed     Abstract available
     
     
     
119. BUJANG NNA, Kong YC, Thiagarajan M, Roslani AC, et al
     Development and validation of a dual language needs assessment tool for people living with colorectal cancer (NeAT-CC).
     PLoS One. 2025;20:e0332930.
     PubMed     Abstract available
     
     
     
120. LAVRINENKO V, Donskaya I, Popov V, Litau E, et al
     Phenotypic profiling of small molecules using cell painting assay in HCT116 colorectal cancer cells.
     PLoS One. 2025;20:e0334025.
     PubMed     Abstract available
     
     
     
121. LIU Q, Lei Y, Liu Z, Han J, et al
     Integrative GWAS and RNA-Seq analysis for target identification and virtual drug screening in colorectal cancer.
     PLoS One. 2025;20:e0333179.
     PubMed     Abstract available
     
     
     
122. ISHII M, Itano O, Iwamoto H, Takami Y, et al
     Hepatic arterial infusion is effective in patients with unresectable colorectal liver metastases refractory to standard systemic chemotherapy: A retrospective cohort study.
     PLoS One. 2025;20:e0336230.
     PubMed     Abstract available
     
     
     
123. KARAKAYALI F, Arslan C, Bisgin T, Erenler Bayraktar I, et al
     Can neoadjuvant chemoradiotherapy be omitted in cT2N+ and cT3 mid-rectal cancer: Protocol for a prospective, observational, cohort study (CANO).
     PLoS One. 2025;20:e0321819.
     PubMed     Abstract available
     
     
     
124. SHARMA P, Sharma B, Noonia A, Yadav DP, et al
     Diagnosis of colorectal cancer using residual transformer with mixed attention and explainable AI.
     PLoS One. 2025;20:e0335418.
     PubMed     Abstract available
     
     
     
125. ORENGO JC, Bierrenbach AL, Aranda Flores CE, Lopez ED, et al
     Trends in the burden of HPV-associated cancers in Mexico: An analysis from 2011 to 2019.
     PLoS One. 2025;20:e0335307.
     PubMed     Abstract available
     
     
     
126. WANG X, Xu J, Mo L, Liu L, et al
     Closed-loop temperature management with internet of things technology support in elderly laparoscopic rectal cancer surgery: A randomised controlled trial.
     PLoS One. 2025;20:e0335993.
     PubMed     Abstract available
     
     
     
127. TIAN Y, Zeng Y, Liu Y, Ye J, et al
     N-glycosylation of NANOG regulates stemness and apoptosis in colon cancer cells.
     PLoS One. 2025;20:e0336779.
     PubMed     Abstract available
     
     
     
128. INOUE A, Morimoto Y, Nishizawa Y, Hashimoto M, et al
     Clinical utility of circulating tumor DNA for early detection of recurrence after curative hepatectomy in patients with colorectal cancer with liver metastases: A prospective observational study protocol (CASSIOPEIA).
     PLoS One. 2025;20:e0335591.
     PubMed     Abstract available
     
     
     
129. ADRIANTO AA, Riwanto I, Sadhana U, Paramita DK, et al
     The efficacy of Pembrolizumab, Ipilimumab, and Nivolumab monotherapy and combination for colorectal cancer: A systematic review and meta-analysis.
     PLoS One. 2025;20:e0307128.
     PubMed     Abstract available
     
     
     
130. AKARAPREDEE N, Atasilp C, Sukasem C, Jinda P, et al
     Impacts of polymorphisms in drug-metabolizing enzyme and transporter genes on irinotecan toxicity and efficacy in Thai colorectal cancer patients.
     PLoS One. 2025;20:e0338442.
     PubMed     Abstract available
     
     
     
131. SUN Y, Zhu G, Lian D, Amin B, et al
     Multi-dimensional analysis of the global burden of colorectal cancer disease from 1990 to 2021 and prediction of future trends: A comprehensive study based on the GBD database.
     PLoS One. 2025;20:e0337216.
     PubMed     Abstract available
     
     
     
132. HOBSON LM, Martin RM, Smith-Byrne K, Davey Smith G, et al
     A protocol for using human genetic data to identify circulating protein level changes that are the causal consequence of cancer processes.
     PLoS One. 2025;20:e0312970.
     PubMed     Abstract available
     
     
     
133. ZHOU H, Fang L
     Integrated transcriptomic analysis reveals a CEBPB-DUSP1 axis driving tumor progression in colorectal cancer.
     PLoS One. 2025;20:e0337892.
     PubMed     Abstract available
     
     
     
134. HU J, Chen Z, Ma C, Fang Y, et al
     Analyses of the roles and potential targets of m7G-related genes in colorectal cancer using single-cell and bulk RNA sequencing data.
     PLoS One. 2025;20:e0337288.
     PubMed     Abstract available
     
     
     
135. 
     Correction: Additional outreach effort of providing an opportunity to obtain a kit for fecal immunochemical test during the general health check-up to improve colorectal cancer screening rate in Japan: A longitudinal study.
     PLoS One. 2025;20:e0339049.
     PubMed     Abstract available
     
     
     
136. FAN G, Zhang K, Yang X, Ding J, et al
     Correction: Prognostic value of circulating tumor DNA in patients with colon cancer: Systematic review.
     PLoS One. 2025;20:e0338537.
     PubMed     Abstract available
     
     
     
137. ALYABSI MS, Alqarni AH, Almutairi AF, Alhalafi MS, et al
     Comparative effectiveness of open versus laparoscopic resection in patients with locally advanced colon cancer: Inverse probability of treatment weighting approach.
     PLoS One. 2025;20:e0338741.
     PubMed     Abstract available
     
     
     January 2024
138. SUN J, Frick KD, Liang H, Chow CM, et al
     Examining cancer screening disparities by race/ethnicity and insurance groups: A comparison of 2008 and 2018 National Health Interview Survey (NHIS) data in the United States.
     PLoS One. 2024;19:e0290105.
     PubMed     Abstract available
     
     
     
139. 
     Correction: What is your count? An observational study of lymph node counting in 2,028 colorectal cancer resections.
     PLoS One. 2024;19:e0299858.
     PubMed     Abstract available
     
     
     
140. MOURA AR, Lopes MEG, Dantas MS, Marques AD, et al
     Spatial-temporal pattern of colorectal cancer mortality in a Northeastern Brazilian State.
     PLoS One. 2024;19:e0298100.
     PubMed     Abstract available
     
     
     
141. 
     Expression of Concern: Cholecystectomy can increase the risk of colorectal cancer: A meta-analysis of 10 cohort studies.
     PLoS One. 2024;19:e0300484.
     PubMed    
     
     
     
142. GHANIPOUR L, Jansson Palmer G, Nilsson PJ, Nordenvall C, et al
     Efficacy of hyperthermic intraperitoneal chemotherapy in colorectal cancer: A phase I and III open label randomized controlled registry-based clinical trial protocol.
     PLoS One. 2024;19:e0294018.
     PubMed     Abstract available
     
     
     
143. KESSLER LG, Comstock B, Aiello Bowles EJ, Mou J, et al
     Protocol to measure validity and reliability of colorectal, breast, cervical and lung cancer screening questions from the 2021 National Health Interview Survey: Methodology and design.
     PLoS One. 2024;19:e0297773.
     PubMed     Abstract available
     
     
     
144. YANG Y, Mirzaei G
     Performance analysis of data resampling on class imbalance and classification techniques on multi-omics data for cancer classification.
     PLoS One. 2024;19:e0293607.
     PubMed     Abstract available
     
     
     
145. BOUALI A, Spissu Y, Barberis A, Fadda A, et al
     Phytochemical evaluation and exploration of some biological activities of aqueous and ethanolic extracts of two species of the genus Plantago L.
     PLoS One. 2024;19:e0298518.
     PubMed     Abstract available
     
     
     
146. MARTINY FHJ, Bie AKL, Jauernik CP, Rahbek OJ, et al
     Deaths and cardiopulmonary events following colorectal cancer screening-A systematic review with meta-analyses.
     PLoS One. 2024;19:e0295900.
     PubMed     Abstract available
     
     
     
147. WANG X, Wang Y, Cao X, Zhang C, et al
     Underwater versus conventional endoscopic mucosal resection for >/=10 mm sessile or flat colorectal polyps: A systematic review and meta-analysis.
     PLoS One. 2024;19:e0299931.
     PubMed     Abstract available
     
     
     
148. CARR M, Thompson C, Berger-Gillam T, Freedman J, et al
     Testing a faith-placed education intervention for bowel cancer screening in Muslim communities using a two-group non-randomised mixed-methods approach: Feasibility study protocol.
     PLoS One. 2024;19:e0293339.
     PubMed     Abstract available
     
     
     
149. HOANG KD, Chen JH, Huang TW, Kang YN, et al
     Oral aspirin for preventing colorectal adenoma recurrence: A systematic review and network meta-analysis of randomized controlled trials.
     PLoS One. 2024;19:e0279784.
     PubMed     Abstract available
     
     
     
150. TSAI MH, Cabral DN, Grunert C, Moore JX, et al
     Colorectal cancer survival disparities in the five regions of Georgia.
     PLoS One. 2024;19:e0301027.
     PubMed     Abstract available
     
     
     
151. OKUNO K, Ikemura K, Okamoto R, Oki K, et al
     CAF-associated genes putatively representing distinct prognosis by in silico landscape of stromal components of colon cancer.
     PLoS One. 2024;19:e0299827.
     PubMed     Abstract available
     
     
     
152. WORTHINGTON J, Sun Z, Fu R, Lew JB, et al
     COVID-related disruptions to colorectal cancer screening, diagnosis, and treatment could increase cancer Burden in Australia and Canada: A modelling study.
     PLoS One. 2024;19:e0296945.
     PubMed     Abstract available
     
     
     
153. LIANG Y, Zhang X, Li S, Wang Z, et al
     Comparison of psychological interventions for anxiety, depression, fatigue and quality of life in colorectal cancer survivors: A systematic review and network meta-analysis protocol.
     PLoS One. 2024;19:e0298589.
     PubMed     Abstract available
     
     
     
154. PUSPITANINGTYAS H, Hutajulu SH, Fachiroh J, Anggorowati N, et al
     Diverging likelihood of colon and rectal cancer in Yogyakarta, Indonesia: A cross sectional study.
     PLoS One. 2024;19:e0301191.
     PubMed     Abstract available
     
     
     
155. CHONG DW, Jayaraj VJ, Ab Rahim FI, Syed Soffian SS, et al
     Study protocol for a mixed methods approach to optimize colorectal cancer screening in Malaysia: Integrating stakeholders insights and knowledge-to-action framework.
     PLoS One. 2024;19:e0299659.
     PubMed     Abstract available
     
     
     
156. RUMIN S, Han X, Zeng C, Lv F, et al
     Systematic analysis of cuproptosis abnormalities and functional significance in cancer.
     PLoS One. 2024;19:e0300626.
     PubMed     Abstract available
     
     
     
157. MAEKAWA M, Tanaka A, Ogawa M, Roehrl MH, et al
     Propensity score matching as an effective strategy for biomarker cohort design and omics data analysis.
     PLoS One. 2024;19:e0302109.
     PubMed     Abstract available
     
     
     
158. OGAWA M, Tanaka A, Maekawa M, Namba K, et al
     Protein expression of the amino acid transporter SLC7A5 in tumor tissue is prognostic in early-stage colorectal cancer.
     PLoS One. 2024;19:e0298362.
     PubMed     Abstract available
     
     
     
159. DENG Q, He B, Gao T, Pan Y, et al
     Correction: Up-Regulation of 91H Promotes Tumor Metastasis and Predicts Poor Prognosis for Patients with Colorectal Cancer.
     PLoS One. 2024;19:e0304249.
     PubMed     Abstract available
     
     
     
160. ZAIKA V, Prakash MK, Cheng CY, Schlander M, et al
     Optimal timing of a colonoscopy screening schedule depends on adenoma detection, adenoma risk, adherence to screening and the screening objective: A microsimulation study.
     PLoS One. 2024;19:e0304374.
     PubMed     Abstract available
     
     
     
161. SU Q, Shen J
     Predictive role of preoperative sarcopenia for long-term survival in rectal cancer patients: A meta-analysis.
     PLoS One. 2024;19:e0303494.
     PubMed     Abstract available
     
     
     
162. HUANG Z, Hu X, Wei Y, Lai Y, et al
     ADAMTSL2 is a potential prognostic biomarker and immunotherapeutic target for colorectal cancer: Bioinformatic analysis and experimental verification.
     PLoS One. 2024;19:e0303909.
     PubMed     Abstract available
     
     
     
163. CHAOUCH MA, Hussain MI, Carneiro da Costa A, Mazzotta A, et al
     Robotic versus laparoscopic total mesorectal excision with lateral lymph node dissection for advanced rectal cancer: A systematic review and meta-analysis.
     PLoS One. 2024;19:e0304031.
     PubMed     Abstract available
     
     
     
164. MAHDOUANI M, Zhuri D, Sezginer Guler H, Hmida D, et al
     Functional analysis of MMR gene VUS from potential Lynch syndrome patients.
     PLoS One. 2024;19:e0304141.
     PubMed     Abstract available
     
     
     
165. FIRESTEIN R, Blander G, Michan S, Oberdoerffer P, et al
     Correction: The SIRT1 Deacetylase Suppresses Intestinal Tumorigenesis and Colon Cancer Growth.
     PLoS One. 2024;19:e0305277.
     PubMed     Abstract available
     
     
     
166. SEUFFERLEIN T, Lausser L, Stein A, Arnold D, et al
     Prediction of resistance to bevacizumab plus FOLFOX in metastatic colorectal cancer-Results of the prospective multicenter PERMAD trial.
     PLoS One. 2024;19:e0304324.
     PubMed     Abstract available
     
     
     
167. PROMSUT K, Sangtanoo P, Srimongkol P, Saisavoey T, et al
     A novel peptide derived from Zingiber cassumunar rhizomes exhibits anticancer activity against the colon adenocarcinoma cells (Caco-2) via the induction of intrinsic apoptosis signaling.
     PLoS One. 2024;19:e0304701.
     PubMed     Abstract available
     
     
     
168. DARWISH MK, Allayeh AK, Ahmed AE, Abdelmaksoud MDE, et al
     Case-control study: Unveiling human polyomaviruses and papillomavirus in Egyptian colorectal cancer patients.
     PLoS One. 2024;19:e0304147.
     PubMed     Abstract available
     
     
     
169. BOSCH NM, Kalkdijk-Dijkstra AJ, Broens PMA, van Westreenen HL, et al
     Implementation of Pelvic Floor Rehabilitation after rectal cancer surgery: A qualitative study guided by the Consolidated Framework for Implementation Research (CFIR).
     PLoS One. 2024;19:e0301518.
     PubMed     Abstract available
     
     
     
170. JIRAPONGWATTANA N, Thongchot S, Pongpaibul A, Trakarnsanga A, et al
     The combined tumour-based Fascin/Snail and stromal periostin reveals the effective prognosis prediction in colorectal cancer patients.
     PLoS One. 2024;19:e0304666.
     PubMed     Abstract available
     
     
     
171. ZHANG X, Li W, Wang X, Lin J, et al
     Effectiveness of D-dimer in predicting distant metastasis in colorectal cancer.
     PLoS One. 2024;19:e0306909.
     PubMed     Abstract available
     
     
     
172. LIN L, Fang Y, Huang F, Zhang X, et al
     Discharge teaching quality positively predicts quality of life in colorectal cancer patients with temporary enterostomy: The mediating role of readiness for hospital discharge and stoma self-efficacy.
     PLoS One. 2024;19:e0306981.
     PubMed     Abstract available
     
     
     
173. HUANG X, Wang L, Jiang S, Xu L, et al
     DHAFormer: Dual-channel hybrid attention network with transformer for polyp segmentation.
     PLoS One. 2024;19:e0306596.
     PubMed     Abstract available
     
     
     
174. LOVALL C, Mjelde LME, Eide LSP, Reime MH, et al
     Patients' experiences of living with low anterior resection syndrome three to six months after colorectal cancer surgery: A phenomenological study.
     PLoS One. 2024;19:e0305212.
     PubMed     Abstract available
     
     
     
175. YUSUF H, Gupta V, Osaghae I, Kumar A, et al
     Longitudinal impact of screening colonoscopy on greenhouse gas emissions.
     PLoS One. 2024;19:e0307133.
     PubMed     Abstract available
     
     
     
176. YANG C, Chang Z, Dai Y, Mo J, et al
     Trans-ancestry analysis in over 799,000 individuals yields new insights into the genetic etiology of colorectal cancer.
     PLoS One. 2024;19:e0301811.
     PubMed     Abstract available
     
     
     
177. WU CY, Zhong WJ, Ye K
     Preliminary study of indocyanine green-guided laparoscopic lateral lymph node dissection for rectal cancer.
     PLoS One. 2024;19:e0307077.
     PubMed     Abstract available
     
     
     
178. AJAB SM, Zoughbor SH, Labania LA, Ostlundh LM, et al
     Microbiota composition effect on immunotherapy outcomes in colorectal cancer patients: A systematic review.
     PLoS One. 2024;19:e0307639.
     PubMed     Abstract available
     
     
     
179. BROEKMAN M, Genders CMS, Geitenbeek RTJ, Havenga K, et al
     Unraveling the role of computed tomography derived body composition metrics on anastomotic leakages rates in rectal cancer surgery: A protocol for a systematic review and meta-analysis.
     PLoS One. 2024;19:e0307606.
     PubMed     Abstract available
     
     
     
180. KHANAL M, Acharya A, Maharjan R, Gyawali K, et al
     Identification of potent inhibitors of HDAC2 from herbal products for the treatment of colon cancer: Molecular docking, molecular dynamics simulation, MM/GBSA calculations, DFT studies, and pharmacokinetic analysis.
     PLoS One. 2024;19:e0307501.
     PubMed     Abstract available
     
     
     
181. DE LAS HERAS F, Mitchell CB, Murray WK, Clemons NJ, et al
     Development of an in vivo syngeneic mouse transplant model of invasive intestinal adenocarcinoma driven by endogenous expression of Pik3caH1047R and Apc loss.
     PLoS One. 2024;19:e0308051.
     PubMed     Abstract available
     
     
     
182. WANG G, Hiramoto K, Ma N, Ohnishi S, et al
     Immunohistochemical analyses reveal FoxP3 expressions in spleen and colorectal cancer in mice treated with AOM/DSS, and their suppression by glycyrrhizin.
     PLoS One. 2024;19:e0307038.
     PubMed     Abstract available
     
     
     
183. NORTHROP-ALBRECHT EJ, Wu CW, Berger CK, Taylor WR, et al
     An investigation of plasma cell-free RNA for the detection of colorectal cancer: From transcriptome marker selection to targeted validation.
     PLoS One. 2024;19:e0308711.
     PubMed     Abstract available
     
     
     
184. ALMUTAIRI MH, Alrubie TM, Alshareeda AT, Albarakati N, et al
     Differential expression and regulation of ADAD1, DMRTC2, PRSS54, SYCE1, SYCP1, TEX101, TEX48, and TMPRSS12 gene profiles in colon cancer tissues and their in vitro response to epigenetic drugs.
     PLoS One. 2024;19:e0307724.
     PubMed     Abstract available
     
     
     
185. NG AP, Kim S, Chervu N, Gao Z, et al
     Disparities in outcomes of colorectal cancer surgery among adults with intellectual and developmental disabilities.
     PLoS One. 2024;19:e0308938.
     PubMed     Abstract available
     
     
     
186. ZHANG M, Li W, Zhao Y, Qi L, et al
     Molecular characterization analysis of PANoptosis-related genes in colorectal cancer based on bioinformatic analysis.
     PLoS One. 2024;19:e0307651.
     PubMed     Abstract available
     
     
     
187. BALTA B, Taylor L, Bogale N, Hailu D, et al
     Survival and predictors of mortality among colorectal cancer patients on follow-up in Hawassa University Comprehensive Specialized Hospital, Sidama region, Southern Ethiopia, 2022. A 5-year retrospective cohort study.
     PLoS One. 2024;19:e0304820.
     PubMed     Abstract available
     
     
     
188. OGUNDIPE O, Kurt Z, Woo WL
     Deep neural networks integrating genomics and histopathological images for predicting stages and survival time-to-event in colon cancer.
     PLoS One. 2024;19:e0305268.
     PubMed     Abstract available
     
     
     
189. MONTAGNON E, Cerny M, Hamilton V, Derennes T, et al
     Radiomics analysis of baseline computed tomography to predict oncological outcomes in patients treated for resectable colorectal cancer liver metastasis.
     PLoS One. 2024;19:e0307815.
     PubMed     Abstract available
     
     
     
190. PERRIN ML, Bassetti C, Durand Fontanier S, Yardin C, et al
     Effects of HyaRegen gel on tumour proliferation of colorectal peritoneal metastases.
     PLoS One. 2024;19:e0307965.
     PubMed     Abstract available
     
     
     
191. HEZI H, Shats D, Gurevich D, Maruvka YE, et al
     Exploring the interplay between colorectal cancer subtypes genomic variants and cellular morphology: A deep-learning approach.
     PLoS One. 2024;19:e0309380.
     PubMed     Abstract available
     
     
     
192. CHEN XF, Liu PG, Sheng N, Li XS, et al
     Arctigenin inhibits the progression of colorectal cancer through epithelial-mesenchymal transition via PI3K/Akt/mTOR signaling pathway.
     PLoS One. 2024;19:e0308947.
     PubMed     Abstract available
     
     
     
193. MA T, Qin Z, Xu G, Zheng PW, et al
     Negative prognostic impact of tumor deposits in stage III colorectal cancer patients.
     PLoS One. 2024;19:e0310327.
     PubMed     Abstract available
     
     
     
194. AHMAD MS, Braoudaki M, Siddiqui SS
     Differential expression of ST6GALNAC1 and ST6GALNAC2 and their clinical relevance to colorectal cancer progression.
     PLoS One. 2024;19:e0311212.
     PubMed     Abstract available
     
     
     
195. TAN J, Yuan J, Fu X, Bai Y, et al
     Colonoscopy polyp classification via enhanced scattering wavelet Convolutional Neural Network.
     PLoS One. 2024;19:e0302800.
     PubMed     Abstract available
     
     
     
196. WONGPRAYOON P, Pengnam S, Srisuphan R, Opanasopit P, et al
     The correlation between cellular O-GlcNAcylation and sensitivity to O-GlcNAc inhibitor in colorectal cancer cells.
     PLoS One. 2024;19:e0312173.
     PubMed     Abstract available
     
     
     
197. SAHEBNASAGH R, Deli H, Shadboorestan A, Vakili-Ghartavol Z, et al
     Identification of key lncRNAs associated with oxaliplatin resistance in colorectal cancer cells and isolated exosomes: From In-Silico prediction to In-Vitro validation.
     PLoS One. 2024;19:e0311680.
     PubMed     Abstract available
     
     
     
198. GARCIA MENENDEZ G, Sichel L, Lopez MDC, Hernandez Y, et al
     From colon wall to tumor niche: Unraveling the microbiome's role in colorectal cancer progression.
     PLoS One. 2024;19:e0311233.
     PubMed     Abstract available
     
     
     
199. SIDDIQUE S, Baum LVM, Deziel NC, Kelly JR, et al
     Using a Bayesian analytic approach to identify county-level ecological factors associated with survival among individuals with early-onset colorectal cancer.
     PLoS One. 2024;19:e0311540.
     PubMed     Abstract available
     
     
     
200. MASROUR M, Khanmohammadi S, Habibzadeh A, Fallahtafti P, et al
     LncRNA MALAT1 as diagnostic and prognostic biomarker in colorectal cancers: A systematic review and meta-analysis.
     PLoS One. 2024;19:e0308009.
     PubMed     Abstract available
     
     
     
201. LI R, Chen J, Shen X, Lin Y, et al
     A study of the clinical significance of mSEPT9 in monitoring recurrence and prognosis in patients with surgically treated colorectal cancer.
     PLoS One. 2024;19:e0312676.
     PubMed     Abstract available
     
     
     
202. MOUSAVI KAHAKI SA, Ebrahimzadeh N, Fahimi H, Moshiri A, et al
     Development of an optimized protocol for generating knockout cancer cell lines using the CRISPR/Cas9 system, with emphasis on transient transfection.
     PLoS One. 2024;19:e0310368.
     PubMed     Abstract available
     
     
     
203. LAL A, Mohebi M, Wyatt K, Ghosh A, et al
     Tailored recruitment interventions to improve bowel cancer screening in Arabic and Mandarin speaking groups: Modelled cost-effectiveness.
     PLoS One. 2024;19:e0313058.
     PubMed     Abstract available
     
     
     
204. ZHU Z, Lam TYT, Tang RSY, Wong SH, et al
     Triglyceride-glucose index (TyG index) is associated with a higher risk of colorectal adenoma and multiple adenomas in asymptomatic subjects.
     PLoS One. 2024;19:e0310526.
     PubMed     Abstract available
     
     
     
205. 
     Expression of Concern: Curcumin Enhances the Effect of Chemotherapy against Colorectal Cancer Cells by Inhibition of NF-kappaB and Src Protein Kinase Signaling Pathways.
     PLoS One. 2024;19:e0314637.
     PubMed    
     
     
     
206. CORREA-MEDERO RL, Pai R, Ebare K, Buchanan DD, et al
     Causal debiasing for unknown bias in histopathology-A colon cancer use case.
     PLoS One. 2024;19:e0303415.
     PubMed     Abstract available
     
     
     
207. GHOBASHI AH, Kimani JW, Ladaika CA, O'Hagan HM, et al
     PTEN depletion reduces H3K27me3 levels to promote epithelial-to-mesenchymal transition in epithelial colorectal cancer cells.
     PLoS One. 2024;19:e0313769.
     PubMed     Abstract available
     
     
     
208. DENG LQ, Li SY, Xie T, Zeng WQ, et al
     LincROR promotes tumor growth of colorectal cancer through the miR-145/WNT2B/WNT10A/Wnt/beta-catenin regulatory axis.
     PLoS One. 2024;19:e0312417.
     PubMed     Abstract available
     
     
     
209. ESFANDIARI F, Bakhshi B, Shahbazi T, Derakhshan-Nezhad E, et al
     Significant difference in gut microbiota Bifidobacterium species but not Lactobacillus species in colorectal cancer patients in comparison with healthy volunteers using quantitative real-time PCR.
     PLoS One. 2024;19:e0294053.
     PubMed     Abstract available
     
     
     
210. WEINSTEIN SJ, Parisi D, Mondul AM, Layne TM, et al
     Vitamin D binding protein genetic isoforms, serum vitamin D, and cancer risk in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
     PLoS One. 2024;19:e0315252.
     PubMed     Abstract available
     
     
     
211. OKAWA M, Yamakuchi M, Bibek A, Takenouchi K, et al
     Plasma and serum concentrations of VEGF-A121, but not of VEGF-A165, increase post-bevacizumab administration.
     PLoS One. 2024;19:e0316035.
     PubMed     Abstract available
     
     
     
212. AISU Y, Oshima N, Hyodo F, Elhelaly AE, et al
     Dual inhibition of oxidative phosphorylation and glycolysis exerts a synergistic antitumor effect on colorectal and gastric cancer by creating energy depletion and preventing metabolic switch.
     PLoS One. 2024;19:e0309700.
     PubMed     Abstract available
     
     
     
213. ZHANG H, Yi H, Qin S, Liu X, et al
     CLIP-based multimodal endorectal ultrasound enhances prediction of neoadjuvant chemoradiotherapy response in locally advanced rectal cancer.
     PLoS One. 2024;19:e0315339.
     PubMed     Abstract available
     
     
     
214. KORSIRIKOON C, Techaniyom P, Kettawan A, Rungruang T, et al
     Cold-pressed extraction of perilla seed oil enriched with alpha-linolenic acid mitigates tumour progression and restores gut microbial homeostasis in the AOM/DSS mice model of colitis-associated colorectal cancer.
     PLoS One. 2024;19:e0315172.
     PubMed     Abstract available
     
     
     
215. SUN C, Fan E, Huang L, Zhang Z, et al
     Second-line systemic treatment for metastatic colorectal cancer: A systematic review and Bayesian network meta-analysis based on RCT.
     PLoS One. 2024;19:e0313278.
     PubMed     Abstract available
     
     
     
216. WANG D, Wang J, Yao F, Xie Z, et al
     miR-1247-3p regulation of CCND1 affects chemoresistance in colorectal cancer.
     PLoS One. 2024;19:e0309979.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum